​

Funding Round

Series A - Clyde Biosciences

Series A - Clyde Biosciences

Investment Firm

Overview

Improving success in drug discovery

Announced Date

Apr 13, 2015

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Epidarex Capital

Epidarex Capital

Epidarex Capital is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorEpidarex Capital
Participant InvestorUniversity of Glasgow
Participant InvestorScottish Investment Bank

Round Details and Background

Clyde Biosciences raised $2934117 on 2015-04-13 in Series A

Improving success in drug discovery

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 01, 2012
Seed Round - Clyde Biosciences
1-undefined
Sep 01, 2013
Grant - Clyde Biosciences
-undefined
Apr 13, 2015
Series A - Clyde Biosciences
3-2.9M

Recent Activity

There is no recent news or activity for this profile.